Neurology | Physician's Weekly


Deutetrabenazine No Help for Tourette Tics

Phase III study fails after promising early data Deutetrabenazine was not effective in treating tics associated with Tourette syndrome, the phase III ARTISTS 2 trial found.At week 8, the difference in Yale Global Tic Severity...

Some MS Drugs Attenuate Covid-19 Vaccine Response

Vaccination timing, additional doses merit consideration Some disease-modifying treatments (DMTs) used in multiple sclerosis (MS) may attenuate patients’ immune response to SARS-CoV-2 vaccination.The American Academy of...